Funds · compare two funds
Are these two funds really different?
Pick two funds to see how much of their Indian equity is the same: the companies both hold, and what each holds that the other does not.
Data periodFund holdingsEach fund’s latest monthly disclosureNSE prices23 Oct 2026Data status →
UTI - Healthcare Fund vs Motilal Oswal BSE Healthcare ETF
Overlap adds up, for every company both funds hold, the smaller of its two shares of each fund’s disclosed Indian equity: identical portfolios overlap 100%, funds with nothing in common 0%. A figure describes how alike the portfolios are; it is not a judgement of either fund. Method →
See both funds combined in the Portfolio X-ray →
Top shared holdings
42 companies both funds hold · largest common part first
Only in A
2 companies · largest first
Only in B
95 companies · largest first
- Laurus Labs Limited4.84%
- Torrent Pharmaceuticals Limited3.56%
- Zydus Lifesciences Limited1.82%
- Mankind Pharma Limited1.75%
- Krishna Institute of Medical Sciences Limited1.24%
- Neuland Laboratories Limited1.16%
- Wockhardt Limited1.10%
- Acutaas Chemicals Limited1.06%
- Abbott India Limited0.87%
- Piramal Pharma Limited0.81%
- Narayana Hrudayalaya Ltd.0.78%
- Shilpa Medicare Limited0.77%
- Granules India Limited0.76%
- Onesource Specialty Pharma Limited0.75%
- GlaxoSmithKline Pharmaceuticals Limited0.71%
And 80 more.
Sector mix side by side
Share of each fund’s disclosed equity
| Sector | A | B | Difference |
|---|---|---|---|
| Healthcare | 89.7% | 94.1% | -4.44 pp |
| Chemicals | 1.4% | 0.0% | +1.36 pp |
| Not classified | 8.9% | 5.9% | +3.08 pp |
Built from each fund’s latest monthly disclosure of Indian listed shares, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not part of the comparison. Not a recommendation. Method →